Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FG5YU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,159
Award facts
- Contract value 100% obligated
- $11,159.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,159.12 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. The contract, with an ultimate completion date of July 21, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made on a non-set-aside, competitively awarded basis, consistent with AmerisourceBergen's federal procurement track record. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contracting portfolio with DLA and related federal medical supply chains, supplying a comprehensive range of pharmaceutical products, vaccines, and medical devices to support military and veteran healthcare systems. The SPE2DX IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Xolair, an immunologic therapeutic agent, exemplifies the company's role as a critical vendor within the federal medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FG5YU?
SPE2DB25FG5YU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 27, 2025.
How much is contract SPE2DB25FG5YU worth?
The government has obligated $11,159 on SPE2DB25FG5YU.
Is contract SPE2DB25FG5YU an order under another contract?
Yes. SPE2DB25FG5YU is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG5YU competed?
The extent of competition for SPE2DB25FG5YU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award